Eva Nordström
Chief Operating Officer chez ONCOPEPTIDES AB
Fortune : 73 070 $ au 31/03/2024
Profil
Eva Nordström is currently the Chief Operating Officer & Deputy Managing Director at Oncopeptides AB.
She is also a Director at Utilica AB and Oxcia AB.
Previously, she held positions as a Director & Vice President at AstraZeneca AB, Vice President & Director-Global Product at Pharmacia AB, and Vice President & Director-Global Product at AstraZeneca Pharmaceuticals LP.
Ms. Nordström holds an MBA from Stockholm School of Economics and a graduate degree from the University of Uppsala.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ONCOPEPTIDES AB
0,13% | 29/08/2023 | 120 200 ( 0,13% ) | 73 070 $ | 31/03/2024 |
Postes actifs de Eva Nordström
| Sociétés | Poste | Début |
|---|---|---|
| ONCOPEPTIDES AB | Chief Operating Officer | 01/01/2020 |
| Oxcia AB | Director/Board Member | - |
| Utilica AB | Director/Board Member | - |
Anciens postes connus de Eva Nordström
| Sociétés | Poste | Fin |
|---|---|---|
AstraZeneca Pharmaceuticals LP
 AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Corporate Officer/Principal | - |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Director/Board Member | - |
Pharmacia AB /Hillerod Unit/
 Pharmacia AB /Hillerod Unit/ Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Pharmacia AB /Hillerod Unit/ is a pharmaceutical company based in Hillerod, Sweden. Pharmacia AB /Hillerod Unit was acquired by Pharmacia AB /Hillerod UnitManagement/ on January 10, 2001. | Corporate Officer/Principal | - |
Formation de Eva Nordström
| Stockholm School of Economics | Masters Business Admin |
| University of Uppsala | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ONCOPEPTIDES AB | Health Technology |
| Entreprise privées | 5 |
|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
Pharmacia AB /Hillerod Unit/
Pharmacia AB /Hillerod Unit/ Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Pharmacia AB /Hillerod Unit/ is a pharmaceutical company based in Hillerod, Sweden. Pharmacia AB /Hillerod Unit was acquired by Pharmacia AB /Hillerod UnitManagement/ on January 10, 2001. | Health Technology |
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Health Technology |
| Utilica AB | |
| Oxcia AB |
